Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles

Biochemistry
P J LarsonK A High

Abstract

This report describes the expression, purification, and characterization of a series of recombinant factor Xa variants bearing aspartate substitutions for each of the glutamate residues which normally undergo gamma-carboxylation. Factor X was expressed in human embryonic kidney cells and purified from conditioned media by immunoaffinity and hydroxylapatite chromatography. Factor X was activated with Russell's viper venom factor X activator, and single-chain unactivated factor X was removed from activated factor X by size-exclusion chromatography. Recombinant wild-type factor Xa had normal activity in a clotting assay, and mutants with aspartate substitutions for glas residues 16, 26, and 29 had no detectable clotting activity. In purified component assays, these gla variants had essentially no detectable activity in the prothrombinase complex assembled on synthetic phospholipid vesicles but had significant activity when the prothrombinase was assembled on thrombin-activated platelets. In addition, the gla 32 variant had normal activity in the platelet prothrombinase but diminished activity in prothrombinase assembled on synthetic PSPC vesicles. These differences were not accounted for by the total phospholipid composition of th...Continue Reading

Citations

Nov 30, 2006·European Biophysics Journal : EBJ·Olivier Taboureau, Ole Hvilsted Olsen
Oct 18, 2001·Current Opinion in Hematology·B A Bouchard, P B Tracy
Jul 14, 2005·Annual Review of Nutrition·Kathleen L Berkner
Aug 6, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·M BlosteinJ Galipeau
Oct 27, 2004·Cardiology Clinics·Burton E Sobel, David J Schneider
Jul 28, 2016·Nature Medicine·Nabil K ThaljiRodney M Camire
Jan 18, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Christine L KemptonDougald M Monroe
Oct 17, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Edith A NutescuMark D Cipolle
Oct 7, 2005·The Journal of Biological Chemistry·Virginie B Louvain-QuintardBernard F Le Bonniec
Sep 21, 2019·The Biochemical Journal·Tina M MisenheimerBradford S Schwartz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.